A new medication is under research that is having significant impact on a variety of cancers. This medication, still without a name, is in a group of medicines that block a protein called PD-1.
In a recent study, early results have been encouraging in lung cancer, melanoma, and kidney cancer. Even at advanced stages, this new medication can have significant results for certain patients.
A variety of companies are putting great research effort into further development and it is hoped that these medication will be beyond ‘study’ and into practice in approximately a year.
Read more:
http://www.nytimes.com/2012/06/02/business/drug-helps-immune-system-fight-cancer.html?_r=1
http://www.nejm.org/doi/full/10.1056/NEJMoa1200690